## DHR: Danaher Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.9% below STRENGTH zone (3.0-6.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($216.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 1)

**1. Lazard Asset Management LLC Buys 311,332 Shares of Danaher Corporation $DHR**
- Source: MarketBeat | 20251214T140811 | Bullish | Relevance: 100%
- Lazard Asset Management LLC increased its stake in Danaher Corporation (NYSE:DHR) by 10.4% in the second quarter, acquiring 311,332 additional shares to own a total of 3,315,989 shares, valued at approximately $655 million. This makes Danaher its 21st-largest holding, representing about 0.46% of its investment portfolio. Analyst sentiment for Danaher is largely positive, with a "Moderate Buy" consensus rating and a target price of $246.79, stemming from 21 buy ratings versus 4 hold ratings.

**2. Thrivent Financial for Lutherans Grows Stock Holdings in Danaher Corporation $DHR**
- Source: MarketBeat | 20251214T131157 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Danaher Corporation by 6.4%, now holding 804,750 shares valued at approximately $158.98 million. Other institutional investors like Vanguard, Price T. Rowe, and Generation Investment Management also boosted their positions, while Norges Bank initiated a new substantial holding. Despite this institutional accumulation, corporate insiders have recently been net sellers of Danaher stock.

**3. Danaher Stock DHR: What Happened This Week, Latest News, and the Week-Ahead Outlook**
- Source: ts2.tech | 20251213T194649 | Neutral | Relevance: 100%
- Danaher Corporation (NYSE: DHR) concluded the week with a 2.6% decline, underperforming broader markets despite a midweek rebound driven by dividend news and new analyst coverage from Goldman Sachs. The stock is about 12% below its 52-week high, with technical traders watching a key breakout level at $232.34. The outlook for Danaher pivots on macro-economic factors next week, including the US Employment Situation report, Retail Sales, and CPI data, rather than company-specific news.

**4. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $38.29 Million Stock Position in Danaher Corporation $DHR**
- Source: MarketBeat | 20251213T102930 | Somewhat-Bullish | Relevance: 100%
- BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp reduced its stake in Danaher Corporation (NYSE:DHR) by 8.9% in the second quarter, now holding 193,851 shares valued at $38.29 million. Several other institutional investors also adjusted their positions in Danaher. Analyst ratings on DHR are predominantly "Buy," with an average price target of $246.79, while recent insider selling activity has also been reported.

**5. Bronstein, Gewirtz & Grossman, LLC Encourages Danaher Corporation (DHR) Stockholders to Inquire about Securities Investigation**
- Source: FourStatesHomepage.com | 20251212T090805 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has initiated a securities investigation into Danaher Corporation (NYSE: DHR) on behalf of investors who purchased shares before April 21, 2022, and still hold them. The investigation aims to determine if Danaher or its officers engaged in corporate wrongdoing. The firm is encouraging stockholders to contact them for more information and to assist in the investigation at no cost.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Goldman Sachs | $265 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $270 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Goldman Sachs | init | Buy |
| 2025-12-02 | Morgan Stanley | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.20M) |
| Sells | 10 ($75.99M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.6% (+0.2%)
- Blackrock Inc.: 7.4% (+0.1%)
- JPMORGAN CHASE & CO: 5.3% (+404.7%)
- State Street Corpora: 3.9% (-0.3%)
- Capital Internationa: 2.4% (+1.9%)

### Key Risks

1. Heavy insider selling: $76M sold (10 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +3.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 26.9x stretched relative to 9% growth. Balance sheet: $1.4B free cash flow. Insider selling cluster ($76.0M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $162.1B |
| Beta | 0.92 |
| 52W Range | $171.00 - $258.23 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 26.9 |
| Current P/E | 29.3 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.0% to 0.9% (+3.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.0pp (needs >3.0% for momentum thesis). MRS_5 at 0.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.95% (CS: 39) | Neutral |
| RSI_14 | 54.1 | Neutral |
| MACD Histogram | -0.34 | Bearish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 1.112x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $226.33
- **Stop Loss:** $216.53 (4.3% risk)
- **Target:** $236.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 102
- **Position Value:** $23,085.66
- **Portfolio %:** 23.09%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $2.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.72 | $1.89 | +9.8% |
| 2025Q2 | $1.64 | $1.80 | +9.5% |
| 2025Q1 | $1.64 | $1.88 | +14.4% |
| 2024Q4 | $2.16 | $2.14 | -1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*